Yes, anticoagulants can reduce thromboembolism risks in arteriovenous fistulas. Safety and efficacy depend on the patient’s bleeding risk and kidney function.

Anticoagulants may lower thromboembolism risks in arteriovenous fistula patients, but their use must consider the patient’s overall clotting profile and medication tolerance.

While anticoagulants help in reducing thromboembolism in arteriovenous fistulas, their appropriateness depends on factors like patient history of bleeding and current medication interactions.

Anticoagulants are useful for thromboembolism in arteriovenous fistulas, but their safety and efficacy are determined by the individual’s coagulation status and the presence of other comorbidities.